CDNA vs GH
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 28, 2026
CDNA
GH
Investment Advisor Scores
GH
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CDNA | GH | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 200 | 0 | Tie |
| PEG Ratio | -0.12 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 52.2% | 44.3% | CDNA |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 24.0/100 | 46.6/100 | GH |
| Profit Margin | 24.2% | -38.3% | CDNA |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | STRONG SELL | HOLD | GH |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CDNA
MarkupPrice above SMA50, rising 50-day trend (19.4% over 20 days), RSI 69
GH
MarkupPrice above SMA50, rising 50-day trend (2.9% over 20 days), RSI 63
Fundamentals Snapshot
| Metric | CDNA | GH |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 55.9 | -481.5 |
| Trailing P/E | 33.9 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.5% | 0.4% |
| Gross Margin | 0.7% | 0.7% |
| Operating Margin | 0.0% | -0.4% |
| EPS | 2.08 | -3.50 |
| Dividend Yield | — | — |